Nycomed and Baxter receive FDA approval for TachoSil®
- Details
- Category: Nycomed
Nycomed and its partner Baxter International Inc. (NYSE: BAX) received the approval for TachoSil®, a surgical patch, from the US Food and Drug Administration (FDA). TachoSil has been approved as an adjunct to haemostasis (control of bleeding) in cardiovascular surgery.
Novel agent Lu AE04621 enters Lundbeck's development pipeline
- Details
- Category: Lundbeck
H. Lundbeck A/S (Lundbeck) strengthens its pipeline of pharmaceuticals in clinical development by initiating phase I clinical studies with Lu AE04621 in order to investigate safety, tolerability and the pharmacokinetic profile of the drug in humans.
Boehringer Ingelheim launches Global Venture Fund to foster innovation in life sciences
- Details
- Category: Boehringer Ingelheim
Boehringer Ingelheim announced the launch of its corporate venture capital fund, the Boehringer Ingelheim Venture Fund (BIVF). The BIVF aims to invest in Biotech and Start-up companies that provide ground-breaking therapeutic approaches and technologies to help drive innovation in medical science.
GSK and Isis Pharmaceuticals collaborate on RNA therapeutics
- Details
- Category: GlaxoSmithKline
GlaxoSmithKline (GSK) and Isis Pharmaceuticals Inc. announced a new strategic alliance that will apply the Isis antisense drug discovery platform to seek out and develop new therapeutics against targets for rare and serious disease, including infectious diseases and some conditions causing blindness.
Pfizer Posts Details About Interactions With U.S. Physicians
- Details
- Category: Pfizer
Pfizer Inc. released detailed information about how and why the company works with a range of healthcare professionals and researchers to advance patient care and develop lifesaving medicines.
Novo Nordisk Introduces New Industry Resource for Information on Diabetes and Chronic Disease
- Details
- Category: Novo Nordisk
Novo Nordisk, a global healthcare company and leader in diabetes care, today announced the launch of the Novo Nordisk BlueSheet, a resource for information on diabetes and chronic disease, highlighting key issues in diabetes prevention, detection, treatment and care.
Lilly USA Updates Health Education Program to Help Patients with Depression Build Network of Support
- Details
- Category: Eli Lilly and Company
The Support Partners Program offered by Lilly USA shows individuals with depression ways to build their own support group, which, in turn, can help them better deal with their depression symptoms. The Support Partners Program can also help people better understand the illness and the importance of seeking help from a health care professional.
More Pharma News ...
- Dabigatran etexilate shows greater reductions than warfarin
- ratiopharm to become the hub for Teva's European growth strategy
- GlaxoSmithKline update: Government orders for pandemic H1N1 vaccine
- Stimuvax Clinical Program Temporarily Suspended
- Pfizer Signs Long-Term Agreement to Supply Prevenar 13 to The World's Poorest Countries
- Saudi Food and Drug Authority Suspends The Authorisation of Rosiglitazone (Avandia®)
- Abbott Completes Acquisition of STARLIMS Technologies